Estradiol Acetate is Used for treating vasomotor symptoms associated with menopause. It was first introduced by Millicent Holdings Ltd in its drug Femring on Mar 20, 2003. Another drug containing Estradiol Acetate is Femtrace. 2 different companies have introduced drugs containing Estradiol Acetate.

Estradiol Acetate Patents

Given below is the list of patents protecting Estradiol Acetate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Femtrace	US7572779	Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation	Oct 02, 2025	Apil
Femtrace	US6962908	Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation	Dec 21, 2021 (Expired)	Apil
Femtrace	US7799771	Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation	Dec 21, 2021 (Expired)	Apil
Femring	US5855906	Intravaginal drug delivery devices for the administration of 17β-oestradiol precursors	Dec 19, 2015 (Expired)	Millicent

Add above patents to watchlist

Estradiol Acetate's Family Patents

Full family tree